Otmar D. Wiestler
President chez Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Profil
Otmar D.
Wiestler is currently the Chairman at Technische Universität München, the Director at Mark Foundation, and the President at Helmholtz-Gemeinschaft Deutscher Forschungszentren eV.
Previously, he served as the Chairman-Management Board & Scientific Director at German Cancer Research Center, the Medical Director at Life & Brain GmbH, a Professor at the University of Bonn, and an Independent Member-Supervisory Board at Bayer AG.
He obtained his doctorate degree from the University of Freiburg in 1984.
Postes actifs de Otmar D. Wiestler
| Sociétés | Poste | Début |
|---|---|---|
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
 Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | President | 01/09/2015 |
| Technische Universität München | Président | 01/01/2016 |
Mark Foundation
 Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Directeur/Membre du Conseil | 10/05/2023 |
Anciens postes connus de Otmar D. Wiestler
| Sociétés | Poste | Fin |
|---|---|---|
| BAYER AG | Directeur/Membre du Conseil | 26/04/2024 |
German Cancer Research Center
 German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Directeur Général | 01/01/2015 |
| University of Bonn | Corporate Officer/Principal | 01/01/2003 |
LIFE & BRAIN GmbH
 LIFE & BRAIN GmbH Miscellaneous Commercial ServicesCommercial Services LIFE & BRAIN GmbH operates as a development-stage biomedical company. The firm develops novel strategies for the diagnosis and therapy of nervous system disorders. It offers its products and services in different business units: LIFE & BRIAN CellSolutions, Genomics, NeuroEconomics and Electrophysiology services. The company is headquartered in Bonn, Germany. | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Formation de Otmar D. Wiestler
| University of Freiburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BAYER AG | Health Technology |
| Entreprise privées | 4 |
|---|---|
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV
Helmholtz-Gemeinschaft Deutscher Forschungszentren eV Miscellaneous Commercial ServicesCommercial Services Helmholtz-Gemeinschaft Deutscher Forschungszentren eV operates as a scientific research organization. It performs cutting-edge research which contributes substantially to solving the grand challenges of science, society, and industry. The firm focuses on six research fields: Energy, Earth and Environment, Health, Key Technologies, Structure of Matter plus Aeronautics, Space, and Transport. It develops research programs for each of these fields. The company was founded in 1995 and is headquartered in Berlin, Germany. | Commercial Services |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Health Services |
LIFE & BRAIN GmbH
LIFE & BRAIN GmbH Miscellaneous Commercial ServicesCommercial Services LIFE & BRAIN GmbH operates as a development-stage biomedical company. The firm develops novel strategies for the diagnosis and therapy of nervous system disorders. It offers its products and services in different business units: LIFE & BRIAN CellSolutions, Genomics, NeuroEconomics and Electrophysiology services. The company is headquartered in Bonn, Germany. | Commercial Services |
Mark Foundation
Mark Foundation Miscellaneous Commercial ServicesCommercial Services The Mark Foundation for Cancer Research is a charitable organization that partners with scientists worldwide to accelerate research for the prevention, diagnosis, and treatment of cancer. The Mark Foundation is based in New York, NY and was founded by Alexander Mark Knaster. The foundation has awarded over $200 million in grants to more than 100 academic institutions across 13 countries since 2017. The non-profit company's research programs focus on early career support, team science collaboration, new technology innovation, and therapeutics discovery. The foundation also invests in early-stage cancer diagnostics and therapeutics companies. | Commercial Services |
